Tamsulosin

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H28N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G3P28OML5I, chemically known as benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, (r)- but generally known as tamsulosin, which bears US NIH Compound Identifier 129211. European Medicines Agency schedules Tamsulosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10827MIG. The term TAMSULOSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules tamsulosin in its Anatomical Therapeutic Chemical (ATC) Classification. TAMSULOSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tamsulosin under HS 29350090 and SITC 51580. As of Q4 2014, TAMSULOSIN remains the US FDA Preferred Term for this commodity. Tamsulosin bears US NLM identifiers UMLS ID C0257343 and NCI Concept Code C75055. SMILES: S(=O)(=O)(N)C1CC(CC(NCCOC2C(OCC)CCCC2)C)CCC1OC.